{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ-1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Our findings indicate that loss of DJ-1 function leads to neurodegeneration. DJ-1 mutations are associated with PARK7, a monogenic form of human parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as neurodegeneration due to loss of DJ-1 function, relevant to the functional assay."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We transfected wild-type and mutant DJ-1 in cell cultures. Transfection of the DJ-1 carrying the Leu166Pro mutation showed a similar uniform nuclear staining, whereas the cytoplasmic staining appeared mostly colocalized with mitochondria.",
          "judgment": "Yes",
          "reasoning": "The transfection assay used effectively models the disease pathogenesis by showing altered localization of the mutant protein.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_step": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "In COS and PC12 cells transfected with wild-type DJ-1 we observed diffuse cytoplasmic and nuclear DJ-1 immunoreactivity similar to findings from previous studies.",
          "judgment": "Yes",
          "reasoning": "Basic controls were included with wild-type DJ-1, and the results were consistent with previous studies, indicating replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_step": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The mutant DJ-1 (Leu166Pro) is still present in the nucleus, which suggests that the loss of cytoplasmic activities is pathogenic.",
          "judgment": "No",
          "reasoning": "The paper does not mention the use of known pathogenic or benign variant controls in the assay.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The DJ-1 L166P variant shows altered subcellular localization, suggesting a loss of function, which is consistent with the pathogenic mechanism of neurodegeneration. However, due to the lack of variant controls, the evidence strength is limited to PS3_supporting."
    }
  ]
}
